GHRS
GH Research PLC NASDAQ Listed Jun 25, 2021$21.00
Mkt Cap $1.3B
52w Low $9.46
75.9% of range
52w High $24.66
50d MA $16.55
200d MA $14.68
P/E (TTM)
-26.2x
EV/EBITDA
-8.8x
P/B
4.5x
Debt/Equity
0.0x
ROE
—
P/FCF
-17.8x
RSI (14)
—
ATR (14)
—
Beta
1.00
50d MA
$16.55
200d MA
$14.68
Avg Volume
222.8K
GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable 5-MeO-DMT product candidate that has completed two Phase 1 clinical trials and Phase 1/2 clinical trial in patients with TRD. The company also develops GH002, an injectable 5-MeO-DMT product candidate; and GH003, an intranasal 5-MeO-DMT product candidate, which are in preclinical development trials with a focus on psychiatric and neurological disorders. GH Research PLC was incorporated in 2018 and is based in Dublin, Ireland.
28 Baggot Street Lower · Dublin, L2 D02 NX43 · IE
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 8, 2026 | BMO | — | — | — | — | — | — | — | — | — | — | — |
| May 7, 2026 | BMO | — | — | — | 22.44 | -0.5% | -6.4% | — | — | — | — | — |
| Mar 5, 2026 | AMC | -0.29 | -0.23 | +20.7% | 15.17 | +0.6% | +5.0% | +5.3% | +3.9% | -0.3% | +2.3% | — |
| Nov 6, 2025 | AMC | -0.23 | -0.23 | +0.0% | 13.41 | -1.3% | +0.7% | +1.0% | +6.0% | +11.9% | +2.3% | — |
| Aug 7, 2025 | AMC | -0.22 | -0.15 | +31.8% | 12.10 | -0.3% | +2.6% | -2.5% | +0.3% | +3.8% | +5.6% | — |
| May 8, 2025 | AMC | -0.61 | -0.19 | +68.9% | 10.80 | +1.6% | -3.9% | -5.9% | -6.9% | -7.6% | -0.9% | — |
| Feb 27, 2025 | AMC | -0.23 | -0.17 | +26.1% | 10.65 | -2.4% | -4.9% | -13.5% | -11.8% | -2.3% | -0.9% | — |
| Nov 14, 2024 | AMC | -0.25 | -0.23 | +8.0% | 8.97 | +8.5% | +1.3% | +5.6% | +7.1% | +22.1% | +7.2% | — |
| Sep 3, 2024 | AMC | -0.23 | -0.20 | +13.0% | 9.81 | +1.6% | -13.7% | -13.7% | -16.1% | -13.4% | -18.3% | — |
| May 3, 2024 | AMC | -0.22 | -0.15 | +31.8% | 11.68 | +5.3% | +0.1% | +3.4% | +2.7% | +2.7% | +9.7% | — |
| Feb 29, 2024 | AMC | -0.20 | -0.21 | -5.0% | 8.88 | -0.1% | -4.3% | -8.4% | -4.3% | -4.7% | -7.9% | — |
| Nov 9, 2023 | AMC | -0.20 | -0.11 | +45.0% | 7.95 | -1.0% | +3.3% | -5.7% | -4.4% | -1.0% | -7.9% | — |
| Aug 23, 2023 | AMC | -0.25 | -0.15 | +40.0% | 10.50 | +0.7% | -4.0% | -4.4% | +3.1% | +10.0% | +1.9% | — |
| May 11, 2023 | AMC | -0.22 | -0.21 | +4.5% | 10.17 | +6.3% | +4.5% | +7.2% | +3.2% | +8.8% | +4.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 6 | Citizens | Maintains | Market Outperform → Market Outperform | — | $15.17 | $15.26 | +0.6% | +5.0% | +5.3% | +3.9% | -0.3% | +2.3% |
| Mar 6 | Needham | Maintains | Buy → Buy | — | $15.17 | $15.26 | +0.6% | +5.0% | +5.3% | +3.9% | -0.3% | +2.3% |
| Mar 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $14.85 | $14.45 | -2.7% | +7.8% | +3.0% | +7.7% | +2.2% | +7.3% |
| Jan 23 | RBC Capital | Maintains | Outperform → Outperform | — | $16.74 | $16.90 | +1.0% | -0.1% | -0.8% | -3.2% | -4.1% | -3.0% |
| Jan 6 | Canaccord Genuity | Maintains | Buy → Buy | — | $15.46 | $16.02 | +3.6% | -8.7% | +16.1% | +0.6% | -2.9% | -1.6% |
| Jan 6 | Needham | Maintains | Buy → Buy | — | $15.46 | $16.02 | +3.6% | -8.7% | +16.1% | +0.6% | -2.9% | -1.6% |
| Jan 5 | Needham | Maintains | Buy → Buy | — | $13.24 | $18.82 | +42.1% | +16.8% | +6.6% | +35.6% | +17.4% | +13.4% |
| Nov 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $13.50 | $13.74 | +1.8% | +0.3% | +5.3% | +11.1% | +1.6% | +3.7% |
| Jun 24 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $11.68 | $11.76 | +0.7% | +7.4% | +1.8% | +6.2% | +6.5% | +4.4% |
| May 9 | Guggenheim | Maintains | Buy → Buy | — | $10.80 | $10.97 | +1.6% | -3.9% | -5.9% | -6.9% | -7.6% | -0.9% |
| May 9 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $10.80 | $10.97 | +1.6% | -3.9% | -5.9% | -6.9% | -7.6% | -0.9% |
| Feb 27 | Stifel | Maintains | Buy → Buy | — | $10.97 | $11.00 | +0.3% | -2.9% | -7.7% | -16.0% | -14.4% | -5.1% |
| Jan 27 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.83 | $8.94 | +1.2% | -0.2% | +7.6% | +6.8% | +9.7% | +20.0% |
| Jan 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.57 | $8.29 | -3.3% | -2.6% | -4.4% | -1.3% | +0.4% | +3.6% |
| Jan 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.98 | $8.72 | -2.9% | -4.6% | -7.0% | -8.8% | -5.8% | -4.2% |
| Nov 20 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $9.61 | $9.59 | -0.2% | +13.9% | +0.1% | -3.5% | -5.2% | -5.3% |
| Nov 18 | Canaccord Genuity | Maintains | Buy → Buy | — | $9.09 | $9.05 | -0.4% | +4.2% | +5.7% | +20.5% | +5.8% | +2.0% |
| Sep 5 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.47 | $8.56 | +1.1% | +0.0% | -2.8% | +0.4% | -5.4% | -3.9% |
| Sep 4 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $9.81 | $9.97 | +1.6% | -13.7% | -13.7% | -16.1% | -13.4% | -18.3% |
| Jul 31 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $12.18 | $12.48 | +2.5% | +1.8% | +1.2% | -2.1% | -6.0% | -8.5% |
| May 7 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $11.69 | $11.75 | +0.5% | +3.3% | +2.6% | +2.6% | +9.6% | +10.2% |
| May 6 | Canaccord Genuity | Maintains | Buy → Buy | — | $11.68 | $12.30 | +5.3% | +0.1% | +3.4% | +2.7% | +2.7% | +9.7% |
| Mar 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.50 | $8.42 | -0.9% | -4.4% | +0.0% | -0.5% | -3.8% | -4.6% |
| Mar 1 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $8.88 | $8.87 | -0.1% | -4.3% | -8.4% | -4.3% | -4.7% | -7.9% |
| Jan 18 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.74 | $5.66 | -1.4% | -1.9% | +1.9% | +5.6% | +6.4% | +9.8% |
| Dec 18 | Stifel | Maintains | Buy → Buy | — | $5.59 | $5.56 | -0.5% | -5.9% | +2.7% | -4.8% | -5.5% | -1.8% |
| Nov 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.50 | $7.65 | +2.0% | +1.3% | +4.9% | -2.4% | -13.9% | -17.6% |
| Jul 6 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $12.50 | $12.63 | +1.0% | +0.7% | +1.6% | -0.4% | +0.4% | +2.6% |
| May 12 | JMP Securities | Maintains | Outperform → Outperform | — | $10.17 | $10.81 | +6.3% | +4.5% | +7.2% | +3.2% | +8.8% | +4.6% |
| May 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $10.17 | $10.81 | +6.3% | +4.5% | +7.2% | +3.2% | +8.8% | +4.6% |
| Apr 13 | Canaccord Genuity | Maintains | Buy → Buy | — | $19.42 | $19.50 | +0.4% | -0.5% | +0.0% | -1.8% | -1.9% | -4.2% |
No insider trades available.
No recent filings available.
Data updated apr 25, 2026 11:22am
· Source: massive.com